ATRX and central nervous system cancer: Consistent with the fact that the mutation of IDH1 and ATRX is associated with prolonged survival in glioma,36, 37 our result showed that the SNPs in IDH1 and ATRX exerted a higher somatic mutation burden in the low‐risk group than in the high‐risk group.